OPKO Health Swings to Q3 Net Loss of $53.5 Million as Revenue Rises 16%

OPKO Health reported revenue of $65.4 million for the third quarter of 2026, which fell short of the FactSet consensus estimate of $136.6 million. The company's operating loss from continuing operations narrowed to $31.4 million, compared to $33.6 million in the same period of 2025. As of September 30, 2026, the company held $403.2 million in cash, cash equivalents, and restricted cash. Additionally, OPKO Health issued revenue guidance for the fourth quarter of 2026, projecting a range between $62.0 million and $72.0 million. During the quarter, the company also repurchased 7,050,000 shares for approximately $10.6 million, leaving $84.3 million remaining under its $200 million share repurchase authorization.